{"entity":{"id":"nct06840483","kind":"trial","name":"Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer","aka":[],"tldr":"A phase 2 trial of Zelenectide pevedotin in advanced solid tumours, run by BicycleTx Limited, active and no longer recruiting.","summary":"Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer is a phase 2 interventional study registered as NCT06840483 by BicycleTx Limited, with 66 participants enrolled, started 2025-03-03 and due to reach its primary completion in 2028-06-30. Interventions recorded: Zelenectide pevedotin (BT8009).","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06840483","url":"https://clinicaltrials.gov/study/NCT06840483"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["zelenectide-pevedotin"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06840483","phase":"2","setting":"Phase 2 Study of Zelenectide Pevedotin in Participants With NECTIN4 Amplified Advanced Breast Cancer","sponsor":"BicycleTx Limited","enrolled":66,"outcomes":[]},"route":"/trials/nct06840483/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"zelenectide-pevedotin","kind":"drug","name":"Zelenectide pevedotin","route":"/drugs/zelenectide-pevedotin/"}]}}